These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6359576)

  • 1. An immunoassay for human D dimer using monoclonal antibodies.
    Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ
    Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). I. Characterization and preliminary evaluation in plasma.
    Gaffney PJ; Creighton LJ; Perry MJ; Callus M; Thorpe R; Spitz M
    Br J Haematol; 1988 Jan; 68(1):83-90. PubMed ID: 3345297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
    Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
    Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
    Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
    J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the assay for fibrin derivatives using monoclonal antibodies to D-dimer].
    Arai M; Kuroso K; Ikematsu S; Fujimaki M; Fukutake K
    Rinsho Byori; 1986 Feb; 34(2):157-61. PubMed ID: 3517428
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-reactivity of the anti-human D-dimer monoclonal antibody 1C9-6F10 to canine fibrin degradation products.
    Miura N; Furukawa M; Magari Y; Momoi Y
    J Vet Med Sci; 2013 Jul; 75(7):963-6. PubMed ID: 23420644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
    Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
    Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and characterization of McAbs against the human crosslinked fibrin degradation product D-dimer].
    Qi G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):313-6. PubMed ID: 1839247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
    Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.
    Kogan AE; Mukharyamova KS; Bereznikova AV; Filatov VL; Koshkina EV; Bloshchitsyna MN; Katrukha AG
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):542-50. PubMed ID: 26656897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.
    Nieuwenhuizen W
    Blut; 1988 Nov; 57(5):285-91. PubMed ID: 3058234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.